On May 9, 2024, Eledon Pharmaceuticals, Inc closed the transaction. The company has received $49,999,010 from 24 investors pursuant to exemption provided under Regulation D. The company has paid fees $1,617,174 to placements.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.675 USD | +2.49% |
|
-8.50% | +49.44% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.44% | 101M | |
+14.02% | 121B | |
+17.72% | 112B | |
+3.23% | 22.57B | |
-18.59% | 20.82B | |
-14.95% | 16.3B | |
-17.10% | 16.19B | |
-42.36% | 16.17B | |
+0.22% | 13.17B | |
+23.06% | 11.11B |
- Stock Market
- Equities
- ELDN Stock
- News Eledon Pharmaceuticals, Inc.
- Eledon Pharmaceuticals, Inc. announced that it has received $49.99901 million in funding